Biogen board’s replacement for Alex Denner, biotech executive Susan Langer, is said to be the investor’s romantic partner

On Monday night, Biogen announced a change to its board to add Susan Langer as a director, as longtime member Alex Denner and two others leave the board.

While Langer has a long resume in biotech, including a corporate role at Biogen, a stint as a VC, and as a company founder, she is also Denner’s longstanding romantic partner, Endpoints News has been told by people familiar with the situation.

A spokesman for Biogen declined to comment on a relationship between Denner and Langer, but did confirm that Denner nominated her to the board.

“She will bring fresh perspective,” Biogen spokesman Jack Cox said, adding that her qualifications had been reviewed by the board prior to her nomination. “As a former Biogen colleague, she also knows the company and the biotech ecosystem very well.”

Denner and Langer did not immediately respond to several attempts by Endpoints to reach both of…
Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.